Get App
PRE MARKET REPORT
Gift Nifty indicates a negative start for the broader index in India, with a loss of 75.5 points or 0.31 percent. The Nifty futures were trading around the 24,242 level.
All three major US stock indexes showed gains by the closing bell. They gathered momentum during the session after Treasury Secretary Scott Bessent said high tariffs between the U.S. and China were unsustainable. Trump signaled he was open to easing trade tensions between the world’s two largest economies.
The Dow Jones Industrial Average rose 419.59 points, or 1.07%, to 39,606.57, the S&P 500 gained 88.10 points, or 1.67%, to 5,375.86, and the Nasdaq Composite gained 407.63 points, or 2.50%, to 16,708.05.
Asian stocks traded in a tight range at the open Thursday as a global relief rally started to lose steam after the Trump administration’s mixed signals about its plans for China tariffs.
Japan’s Nikkei share increased by over 1 percent while Hong Kong’s Hang Seng also decreased by 0.24 percent, and the Taiwanese benchmark had also decreased by 0.27 percent.
STOCKS TODAY
Biocon
The board has approved the raising of funds up to Rs 4500 crore via the issuance of equity shares, non-convertible debt instruments, along with warrants, by way of qualified institutions placement, rights issue, preferential allotment, or private placements, in one or more tranches.
Bharat Petroleum Corporation
BPCL has entered into a joint venture (JV) agreement with GPS Renewables to establish compressed biogas (CBG) plants across India. This strategic alliance marks a significant step towards advancing India’s energy transition and contributes to BPCL’s net-zero goals.
Adani Green Energy
The company’s subsidiary Adani Hydro Energy Five has entered into a Power Purchase Agreement (PPA) with Uttar Pradesh Power Corporation (UPPCL) for the supply of 1,250 MW of energy storage capacity from pumped hydro storage projects.
Panacea Biotec
The company has received another award worth $5.2 million (approximately Rs 44 crore) from the UNICEF for the supply of 40 million doses of its bivalent oral polio vaccine (bOPV) in Q3 CY2025. In December 2024, it had received an award worth $14.95 million (approximately Rs 127 crore) for the supply of 115 million doses of its bOPV in CY2025.
Max India
The Board has approved the issue price at Rs 150 per equity share for its rights issue worth Rs 125 crore. The rights entitlement ratio is 19 rights equity shares for every 100 equity shares held by eligible shareholders as of the record date of April 29. The rights issue will open on May 7 and close on May 22.
Source – Moneycontrol
Disclaimer: Investments in the Securities market and Mutual Funds are subject to market risks. Read all the related documents carefully before investing | The securities are quoted as an example and not as a recommendation | Brokerage will not exceed the SEBI-prescribed limit | Margins will be collected as per the exchange norms.